Regeneron

www.regeneron.com/

Regeneron is a leading science-based biopharmaceutical company.

Biotechnology Tarrytown, New York 5,000-10,000 employees Public Corporation Founded in 1988

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.

The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%.

Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Skills We're Looking For

AWS Cloud Linux Networking Python System Integration Systems Administration Active Directory Amazon EC2 Amazon S3 Atlassian Confluence Distributed Computing JSON LDAP Scripting Computer Science Chef Software Distributed Systems Ansible Virtual Private Cloud Elastic Load Balancing Atlassian Amazon Elastic Block Store Puppet Monitoring Tools Stash RESTful Web Services Configuration Management Tools Jira Parallel Computing Amazon RDS